CLINICAL_TRIALS
trial_result
· 2017-04-13
Clinical Trial Update: Combination of Hydroxyurea and Verapamil for Refractory Meningiomas [Phase 2]
Summary
This Phase 2 trial evaluating the combination of hydroxyurea and verapamil for refractory meningiomas has completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Utah | Conditions: Cancer, Brain Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13